Jon R. Levine - Nov 7, 2024 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
President and CEO, Director
Signature
/s/ Jon R. Levine
Stock symbol
MRMD
Transactions as of
Nov 7, 2024
Transactions value $
-$6,626
Form type
4
Date filed
11/8/2024, 05:07 PM
Previous filing
Oct 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRMD Common stock Options Exercise $0 +150K +0.73% $0.00 20.6M Nov 7, 2024 Direct F1
transaction MRMD Common stock Tax liability -$6.63K -44K -0.21% $0.15 20.5M Nov 7, 2024 Direct F2
holding MRMD Common stock 6.68M Nov 7, 2024 By the Jon Levine Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Options Exercise $0 -150K -33.33% $0.00 300K Nov 7, 2024 Common Stock, par value $.001 per share 150K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs convert to shares of common stock on a one-for-one basis.
F2 Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of the RSUs.
F3 These shares are held in trust for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 The RSUs were granted on November 7, 2023 and vested as to one-third on November 7, 2024; the remaining two-thirds will vest in four equal installments thereafter, on May 7, 2025, November 7, 2025, May 7, 2026 and November 7, 2026.